Maharashtra’s Food and Drug Administration (FDA) has warned social media influencers, fitness creators and businesses promoting health supplements that misleading advertisements could attract penalties of up to ₹10 lakh. The warning is part of a statewide regulatory crackdown targeting false health claims, unlicensed supplement sales and products containing potentially unauthorised ingredients. The order, announced by FDA Commissioner Tukaram Mundhe on November 20, 2026, extends regulatory scrutiny across the supplement industry’s supply chain, including manufacturers, distributors, pharmacies, gyms and e-commerce platforms.
The action comes as protein powders, weight-loss products, multivitamins, herbal formulations and other nutraceuticals gain popularity through online advertising and influencer marketing. The Maharashtra FDA has specifically cautioned against claims that supplements can cure diseases or are recommended by doctors and nutritionists. It has also made food safety licences or registrations mandatory for establishments such as gyms and pharmacies that sell these products.
Influencers Face Penalties for Misleading Supplement Advertisements
The Maharashtra FDA has made it clear that influencers promoting health supplements are not outside the scope of food safety regulations.
Social media creators who publish misleading advertisements or make unsupported health claims about supplements could face penalties of up to ₹10 lakh.
The restrictions apply to promotional content across platforms, including Instagram and other social media channels. The FDA is particularly concerned about advertisements that present nutritional products as medicines or promise results that are not legally permitted.
Examples of claims that could attract regulatory action include:
- Claiming that a protein powder or supplement can cure a medical condition.
- Promoting a product as a treatment for diabetes or other diseases.
- Describing a supplement as doctor-recommended or nutritionist-recommended without an authorised basis.
- Suggesting that a food supplement can replace prescribed medicines.
- Making exaggerated claims about rapid weight loss, muscle gain or other health outcomes.
The FDA’s position is that health supplements are intended to complement the regular diet. They should not be marketed as medicines or products that can independently treat or prevent diseases.
Maharashtra FDA Introduces Statewide Compliance Requirements
The new compliance order covers a broad range of food and nutrition products, including:
- Health supplements
- Nutraceuticals
- Food for special dietary use
- Food for special medical purposes
- Prebiotic and probiotic foods
- Novel foods
The requirements apply across the supply chain, including manufacturers, brand owners, importers, distributors, warehouses, retailers, pharmacies, gyms, hospital suppliers and e-commerce businesses.
The FDA has directed businesses to follow existing licensing conditions and product approval requirements. It has also warned against misleading representations in advertisements and on product labels.
This means that regulatory responsibility is not limited to the company manufacturing a supplement. Businesses involved in selling, distributing, storing or promoting products may also face scrutiny depending on their activities and the applicable regulations.
Gyms and Pharmacies Must Obtain FSSAI Licences
One of the significant changes is the requirement for gyms, fitness centres, pharmacies and medical stores selling health supplements to obtain the appropriate Food Safety and Standards Authority of India (FSSAI) food licence or registration.
Holding a licence under another law does not automatically satisfy this requirement.
For example, a gym that sells protein powders, pre-workout products or nutritional supplements to its members must comply with the relevant food safety licensing conditions.
Pharmacies and medical stores selling nutraceuticals and other covered products must also meet the requirements.
The move is intended to bring supplement sales under more consistent regulatory oversight, particularly in locations where consumers may purchase products based on recommendations from trainers, influencers or sales representatives.
FDA Bans Disease-Cure and Doctor-Recommended Claims
The regulator has also clarified which types of marketing representations are prohibited for health supplements.
Products cannot claim to treat, cure, mitigate or prevent diseases. The use of descriptions such as “recommended by doctors” or “recommended by nutritionists” is also restricted under the new directions.
The FDA has further prohibited the use of the term “ORS” in product names, brand names or trademarks.
Product labels must provide relevant information, including the product category, intended consumer group, nutrient levels and applicable safety information. Certain products must also carry a prominent “NOT FOR MEDICINAL USE” warning.
These requirements are intended to help consumers distinguish food supplements from pharmaceutical medicines.
For brands and marketing agencies, the changes mean that product descriptions, packaging, advertising campaigns and influencer scripts may need closer regulatory review.
FDA Targets Steroids and Unauthorised Ingredients in Supplements
The crackdown also includes targeted inspections of products suspected of containing undeclared steroids, hormones or pharmaceutical substances.
The FDA has identified several categories for closer scrutiny:
- Sports nutrition and protein supplements
- Weight-loss products
- Sexual-wellness supplements
- Herbal formulations
- Imported health supplements
These categories have attracted regulatory attention because some products may contain ingredients that are not declared on their labels or are not authorised for use in the relevant food products.
The department is also examining products containing ingredients whose approval applications have been rejected by the FSSAI.
Two ingredients specifically identified in the recent enforcement action were Magnesium Acetyl Taurate and Nicotinamide Mononucleotide (NMN). Samples of seized products containing suspected unauthorised ingredients have been sent to laboratories for analysis.
The FDA has not established that every seized product was unsafe. Laboratory results will help determine the nature of the suspected violations and the next regulatory steps.
FDA Seizes Supplement Stocks Worth ₹1.39 Crore
The new compliance order follows a statewide search operation conducted on November 13, 2026.
During the operation, FDA teams inspected 17 establishments across six divisions of Maharashtra and seized products worth approximately ₹1.39 crore.
The seized products were suspected of being substandard, unsafe or misbranded. Samples were sent for laboratory testing.
Maharashtra currently has around 1,100 active food business licences in the health supplement and nutraceutical categories.
| Category | Number of licensees |
|---|---|
| Manufacturers | 313 |
| Relabellers | 759 |
| Repackers | 28 |
| Total | 1,100 |
The department plans to expand inspections across the industry, including manufacturers, importers, distributors, warehouses, pharmacies, gyms and online sellers.
The use of online surveillance and test purchases is also expected to help identify products and advertisements that may violate the regulations.
What the New Rules Mean for Supplement Brands and Influencers
The regulatory action could change how health and fitness products are marketed in Maharashtra.
Brands may need to review their advertising material, packaging, product approvals and influencer agreements to ensure that promotional claims comply with food safety requirements.
Influencers may also need to exercise greater care before accepting supplement sponsorships. Repeating a brand’s claims in a paid promotion does not necessarily protect a creator from regulatory scrutiny.
For gyms and fitness centres, the licensing requirement adds another compliance responsibility when selling nutritional products.
E-commerce platforms and online retailers are also covered by the statewide order, bringing digital supplement sales within the regulator’s enforcement focus.
The Bigger Picture
India’s health supplement market has expanded alongside growing interest in fitness, nutrition, weight management and preventive health. Social media has become an important marketing channel, allowing brands to reach consumers through fitness creators, trainers and lifestyle influencers.
However, the distinction between nutritional products and medicines can become blurred when advertisements promise medical benefits or rapid results. Maharashtra’s action signals a stronger regulatory focus on how supplements are manufactured, sold and promoted.
The crackdown also highlights that responsibility extends beyond manufacturers. Influencers, retailers, gyms and online sellers can all become part of the compliance chain when they advertise or sell regulated products.
Looking Ahead
The Maharashtra FDA is expected to continue inspections across supplement manufacturers, pharmacies, gyms, importers and online sellers. Laboratory findings from the seized products will be important in determining whether further action, including product seizures, licence suspensions or prosecution, is required. Businesses and influencers operating in the sector will need to pay closer attention to product approvals, licensing requirements and the claims used in promotional campaigns.
For consumers, the new measures could improve transparency around supplements and reduce exposure to misleading health advertisements. However, enforcement will be critical to the effectiveness of the order. The coming months will show how consistently the FDA applies the requirements and whether the action leads to broader compliance across India’s rapidly expanding nutrition and wellness industry.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.



